Lilly Consultants To Pre-Inspect Zovant Contract Manufacturing Sites
Executive Summary
Lilly's outside consultants will perform mock inspections of the contracted manufacturing sites producing Zovant, VP-Manufacturing Scott Canute said during a first quarter earnings call April 16.
You may also be interested in...
Merck Sterile Product Manufacturing Difficulties Affect Cancidas, Timoptic
Merck's recently launched antifungal Cancidas is in short supply as a result of manufacturing difficulties affecting the company's sterile product lines
Merck Sterile Product Manufacturing Difficulties Affect Cancidas, Timoptic
Merck's recently launched antifungal Cancidas is in short supply as a result of manufacturing difficulties affecting the company's sterile product lines
Lilly Xigris Action Date Is Oct. 27; FDA Preparing For Advisory Cmte. Review
The FDA user fee action date for Lilly's sepsis therapy Xigris (formerly Zovant) is extended until Oct. 27.